| Ytd | -45.56% | |
| 1y | -70.52% |
| Open | 0.60 | Prev Close | 0.60 | Low | 0.60 | High | 0.63 | Mkt Cap | 17.49M |
| Vol | 40.25K | Avg Vol | 137.62K | EPS | -3.59 | P/E | N/A | Forward P/E | -4.00 |
| Beta | 0.51 | Short Ratio | 0.36 | Inst. Own | 14.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 0.86 | 200-d Avg | 1.39 | 1yr Est | 2.50 |
CELU News
On June 29, 2026, Celularity Inc. (the "Company") entered into a Loan Agreement (the "L
FLORHAM PARK, N.J. and ORLANDO, Fla.
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" o
FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” o
- Celularity Inc. (NASDAQ:CELU) (the "Company"), a longevity-focused regenerative and cellul
FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”),
Entry into a Material Definitive Agreement. As previously disclosed by Celularity Inc. (the "Com
Company advances focused strategy, strengthens balance sheet and positions business for long-term gr
Veteran Financial and M&A Leader Appointed to Integrate Acquisition of Celularity, Scale the Busines
Transaction expected to approximately triple NEXGEL's annual revenue to approximately $35 million an
FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”)
Celularity Inc. (NASDAQ:CELU) (the "Company"), a longevity-focused regenerative and cellular
FLORHAM PARK, N.J., April 17, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”
Celularity (NASDAQ: CELU - Get Free Report) and KALA BIO (NASDAQ: KALA - Get Free Report) are both s
Transaction expected to approximately triple NEXGEL's annual revenue to about $35 million and is
FLORHAM PARK, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”
The transaction represents the most significant milestone in the company's history.
NexGel to acquire Celularity biomaterial products, a deal expected to triple revenue to $35 million
FLORHAM PARK, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”
FLORHAM PARK, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
While Celularity's Biovance® and Biovance 3L products remained eligible for Medicare coverage under
FLORHAM PARK, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
FLORHAM PARK, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
FLORHAM PARK, N.J., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday'
Company on Friday, August 29, 2025, filed quarterly reports on Form 10-Q for the periods ended March
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourt
Shares of M.D.C. Holdings, Inc. (NYSE: MDC) rose sharply in today’s pre-market trading. Sekisui H
Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the comp
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company